Two subsidiaries of Danaher have established what the company refers to as an investment partnership with Innovaccer, a company specializing in artificial intelligence for healthcare.
The companies announced on Thursday that their collaboration is focused on enhancing patient outcomes and experiences via innovative digital and diagnostic solutions. Furthermore, they intend to expedite the integration of precision diagnostics among healthcare providers and population health teams.
The specifics of the partnership agreement were not revealed.
Innovaccer develops software designed to create a comprehensive patient record. According to the company, this technology enables the use of AI to pinpoint care gaps and identify at-risk patients, facilitating targeted interventions to enhance health outcomes.
Danaher, headquartered in Washington, D.C., announced that the investment supports its goal of advancing the shift towards precision medicine through the use of AI-driven diagnostics.
Just before the market closed, Innovaccer announced that it had secured $275 million in a Series F funding round. The funding was backed by various investors, including B Capital Group, Banner Health, Danaher Ventures LLC, Generation Investment Management, Kaiser Permanente, and M12.
Write to Connor Hart at [email protected]
(END) Dow Jones News Services
January 9, 2025, 5:02 PM ET (10:02 PM GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
